Cargando…

Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure

Motivation: Protein–protein interactions (PPIs) are a promising, but challenging target for pharmaceutical intervention. One approach for addressing these difficult targets is the rational design of small-molecule inhibitors that mimic the chemical and physical properties of small clusters of key re...

Descripción completa

Detalles Bibliográficos
Autores principales: Koes, David Ryan, Camacho, Carlos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307105/
https://www.ncbi.nlm.nih.gov/pubmed/22210869
http://dx.doi.org/10.1093/bioinformatics/btr717
_version_ 1782227290152763392
author Koes, David Ryan
Camacho, Carlos J.
author_facet Koes, David Ryan
Camacho, Carlos J.
author_sort Koes, David Ryan
collection PubMed
description Motivation: Protein–protein interactions (PPIs) are a promising, but challenging target for pharmaceutical intervention. One approach for addressing these difficult targets is the rational design of small-molecule inhibitors that mimic the chemical and physical properties of small clusters of key residues at the protein–protein interface. The identification of appropriate clusters of interface residues provides starting points for inhibitor design and supports an overall assessment of the susceptibility of PPIs to small-molecule inhibition. Results: We extract Small-Molecule Inhibitor Starting Points (SMISPs) from protein-ligand and protein–protein complexes in the Protein Data Bank (PDB). These SMISPs are used to train two distinct classifiers, a support vector machine and an easy to interpret exhaustive rule classifier. Both classifiers achieve better than 70% leave-one-complex-out cross-validation accuracy and correctly predict SMISPs of known PPI inhibitors not in the training set. A PDB-wide analysis suggests that nearly half of all PPIs may be susceptible to small-molecule inhibition. Availability: http://pocketquery.csb.pitt.edu. Contact: dkoes@pitt.edu Supplementary information: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-3307105
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-33071052012-03-19 Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure Koes, David Ryan Camacho, Carlos J. Bioinformatics Original Papers Motivation: Protein–protein interactions (PPIs) are a promising, but challenging target for pharmaceutical intervention. One approach for addressing these difficult targets is the rational design of small-molecule inhibitors that mimic the chemical and physical properties of small clusters of key residues at the protein–protein interface. The identification of appropriate clusters of interface residues provides starting points for inhibitor design and supports an overall assessment of the susceptibility of PPIs to small-molecule inhibition. Results: We extract Small-Molecule Inhibitor Starting Points (SMISPs) from protein-ligand and protein–protein complexes in the Protein Data Bank (PDB). These SMISPs are used to train two distinct classifiers, a support vector machine and an easy to interpret exhaustive rule classifier. Both classifiers achieve better than 70% leave-one-complex-out cross-validation accuracy and correctly predict SMISPs of known PPI inhibitors not in the training set. A PDB-wide analysis suggests that nearly half of all PPIs may be susceptible to small-molecule inhibition. Availability: http://pocketquery.csb.pitt.edu. Contact: dkoes@pitt.edu Supplementary information: Supplementary data are available at Bioinformatics online. Oxford University Press 2012-03-15 2011-12-30 /pmc/articles/PMC3307105/ /pubmed/22210869 http://dx.doi.org/10.1093/bioinformatics/btr717 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Koes, David Ryan
Camacho, Carlos J.
Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure
title Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure
title_full Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure
title_fullStr Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure
title_full_unstemmed Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure
title_short Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure
title_sort small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307105/
https://www.ncbi.nlm.nih.gov/pubmed/22210869
http://dx.doi.org/10.1093/bioinformatics/btr717
work_keys_str_mv AT koesdavidryan smallmoleculeinhibitorstartingpointslearnedfromproteinproteininteractioninhibitorstructure
AT camachocarlosj smallmoleculeinhibitorstartingpointslearnedfromproteinproteininteractioninhibitorstructure